-
Hi, I was finally diagnosed last July after 2.5 years of symptoms. My first genetic test in April of 2022 was all negative but we did another one this past February and the ATXN2 mutation came back positive for intermediate repeats of CAG (32). No one in my family history has had als. Biogen, who produced Toferson for the SOD1 gene mutation was working on clinical trials for knocking down the ATXN2 protein but despite positive results in mouse models there was no success with people. They ended it in 2022 I believe. I tried emailing the company but no response. How are you doing? I’m going back to clinic next week and plan to discuss with my Neurologist.